George Mooney

Dr. George Mooney has over 30 years industrial experience, most recently as EVP for pharmaceutical sciences at Thesan. Previously, George was VP for the Exploratory Development Portfolio at Pfizer, as well as VP of Pharmaceutical Sciences, Pfizer Europe. While extensively experienced in the CMC area (Chemistry, Manufacturing and Controls) George has led and managed multi-disciplinary Teams at all stages of Drug Development. Other former companies include at GD Searle, Boehringer Ingelheim (USA) and American Cyanamid (Lederle) Co. Dr. Mooney has been associated with 30+ NDAs and sNDA’s, most notably Voriconazole (Vfend oral and IV for the acute treatment of Aspergillosis which required co- development of special excipient) and Viagra (Sildenifil for the treatment of Erectile Dysfunction). Additionally, throughout his career he has been responsible for over 80 IND filings, primarily covering NCE’s across the majority of therapeutic areas and associated routes of delivery (Oral, Parenteral, Inhalation, Topical and Ophthalmic). Significant Topical and Ophthalmic experience has been gained in the development of Prostaglandins, Antibiotics and most recently a novel peptide for the treatment of AMD. He qualified as a Pharmacist in the UK (B.Pharm, MSc University of London) and gained his PhD at University of Kansas in Pharmaceutical Sciences. He is a William Pitt Fellow at Pembroke College Cambridge UK, a member of the American Association of Pharmaceutical Scientists and of the Royal Pharmaceutical Society of Great Britain.